Monday, June 18, 2012 5:45:04 PM
I don't think it's Fonged, I think shareholders have been Dyned. In a bk, the debtholders obviously get preference and most of the shareholders get hosed. I think the bk filing showed 14 mill in debt and 6 mill in assets. I wonder what the tech is worth? If it has value, but it hasn't been fully brought to fruition, then the court may value it at almost nothing. However, if shareholders have been Mark Dyned, then my guess is that he's part of the noteholders/lenders, has priority and could walk away with the tech and finish screwing shareholders so he gets it all. If that's not his objective then this is D.O.A. Either way, common shareholders are screwed.
Hey, I thought there was some "lawsuit" going on? That lawsuit could have stayed the bk if it had some validity or at least thrown a monkey wrench into the works. I recall people posting or emailing share counts. How did that play out?
Hey, I thought there was some "lawsuit" going on? That lawsuit could have stayed the bk if it had some validity or at least thrown a monkey wrench into the works. I recall people posting or emailing share counts. How did that play out?
Warren Buffett spent eight years working with it before discarding it as worthless. What investment strategy is that? Technical analysis - aka CHARTS
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
